4.4 Article

Fibroblasts from idiopathic Parkinson's disease exhibit deficiency of lysosomal glucocerebrosidase activity associated with reduced levels of the trafficking receptor LIMP2

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Biochemistry & Molecular Biology

Progranulin mutations result in impaired processing of prosaposin and reduced glucocerebrosidase activity

Clarissa Valdez et al.

HUMAN MOLECULAR GENETICS (2020)

Review Biochemistry & Molecular Biology

The biochemical basis of interactions between Glucocerebrosidase and alpha-synuclein in GBA1 mutation carriers

Marco Toffoli et al.

JOURNAL OF NEUROCHEMISTRY (2020)

Article Multidisciplinary Sciences

The GTEx Consortium atlas of genetic regulatory effects across human tissues

Francois Aguet et al.

SCIENCE (2020)

Review Immunology

Lipid and immune abnormalities causing age-dependent neurodegeneration and Parkinson's disease

Penelope J. Hallett et al.

JOURNAL OF NEUROINFLAMMATION (2019)

Article Multidisciplinary Sciences

Progranulin deficiency leads to reduced glucocerebrosidase activity

Xiaolai Zhou et al.

PLOS ONE (2019)

Article Clinical Neurology

Autophagy lysosomal pathway dysfunction in Parkinson's disease; evidence from human genetics

Konstantin Senkevich et al.

PARKINSONISM & RELATED DISORDERS (2019)

Review Clinical Neurology

The lysosomal function of progranulin, a guardian against neurodegeneration

Daniel H. Paushter et al.

ACTA NEUROPATHOLOGICA (2018)

Article Clinical Neurology

Is Parkinson's disease a lysosomal disorder?

Andres D. Klein et al.

Article Geriatrics & Gerontology

Mutation analysis of Parkinson's disease genes in a Russian data set

Anton K. Emelyanov et al.

NEUROBIOLOGY OF AGING (2018)

Article Geriatrics & Gerontology

Glycosphingolipid levels and glucocerebrosidase activity are altered in normal aging of the mouse brain

Penelope J. Hallett et al.

NEUROBIOLOGY OF AGING (2018)

Article Biochemistry & Molecular Biology

Progranulin functions as a cathepsin D chaperone to stimulate axonal outgrowth in vivo

Sander Beel et al.

HUMAN MOLECULAR GENETICS (2017)

Article Clinical Neurology

Cerebrospinal Fluid β-Glucocerebrosidase Activity Is Reduced in Parkinson's Disease Patients

Lucilla Parnetti et al.

MOVEMENT DISORDERS (2017)

Article Clinical Neurology

N370S-GBA1 Mutation Causes Lysosomal Cholesterol Accumulation in Parkinson's Disease

Patricia Garcia-Sanz et al.

MOVEMENT DISORDERS (2017)

Review Neurosciences

Selective neuronal vulnerability in Parkinson disease

D. James Surmeier et al.

NATURE REVIEWS NEUROSCIENCE (2017)

Review Neurosciences

The Threshold Theory for Parkinson's Disease

Simone Engelender et al.

TRENDS IN NEUROSCIENCES (2017)

Article Neurosciences

Fibroblast Biomarkers of Sporadic Parkinson's Disease and LRRK2 Kinase Inhibition

G. A. Smith et al.

MOLECULAR NEUROBIOLOGY (2016)

Article Clinical Neurology

Specifically neuropathic Gaucher's mutations accelerate cognitive decline in Parkinson's

Ganqiang Liu et al.

ANNALS OF NEUROLOGY (2016)

Article Geriatrics & Gerontology

Strong association between glucocerebrosidase mutations and Parkinson's disease in Sweden

Caroline Ran et al.

NEUROBIOLOGY OF AGING (2016)

Article Multidisciplinary Sciences

Characterization of the complex formed by β-glucocerebrosidase and the lysosomal integral membrane protein type-2

Friederike Zunke et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)

Article Medicine, General & Internal

Progranulin Recruits HSP70 to β-Glucocerebrosidase and Is Therapeutic Against Gaucher Disease

Jinlong Jian et al.

EBIOMEDICINE (2016)

Article Medicine, General & Internal

Association Between Progranulin and Gaucher Disease

Jinlong Jian et al.

EBIOMEDICINE (2016)

Article Multidisciplinary Sciences

Parkinson disease-linked GBA mutation effects reversed by molecular chaperones in human cell and fly models

Alvaro Sanchez-Martinez et al.

SCIENTIFIC REPORTS (2016)

Article Neurosciences

SCARB2 variants and glucocerebrosidase activity in Parkinson's disease

Roy N. Alcalay et al.

NPJ PARKINSONS DISEASE (2016)

Article Neurosciences

Glucocerebrosidase gene therapy prevents α-synucleinopathy of midbrain dopamine neurons

Emily M. Rocha et al.

NEUROBIOLOGY OF DISEASE (2015)

Article Clinical Neurology

Association between rs6812193 polymorphism and sporadic Parkinson's disease susceptibility

Qiang Huo et al.

NEUROLOGICAL SCIENCES (2015)

Article Cell Biology

Mannose 6-phosphate-independent Lysosomal Sorting of LIMP-2

Judith Blanz et al.

TRAFFIC (2015)

Article Clinical Neurology

Progressive decline of glucocerebrosidase in aging and Parkinson's disease

Emily M. Rocha et al.

ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2015)

Article Multidisciplinary Sciences

LIMP-2 expression is critical for β-glucocerebrosidase activity and α-synuclein clearance

Michelle Rothaug et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)

Article Endocrinology & Metabolism

Is Parkinson disease associated with lysosomal integral membrane protein type-2?: Challenges in interpreting association data

Emerson Maniwang et al.

MOLECULAR GENETICS AND METABOLISM (2013)

Article Clinical Neurology

The role of SCARB2 as susceptibility factor in Parkinson's disease

Franziska Hopfner et al.

MOVEMENT DISORDERS (2013)

Article Genetics & Heredity

Strikingly Different Clinicopathological Phenotypes Determined by Progranulin-Mutation Dosage

Katherine R. Smith et al.

AMERICAN JOURNAL OF HUMAN GENETICS (2012)

Article Clinical Neurology

Glucocerebrosidase deficiency in substantia nigra of parkinson disease brains

Matthew E. Gegg et al.

ANNALS OF NEUROLOGY (2012)

Review Endocrinology & Metabolism

The role of saposin C in Gaucher disease

Rafael J. Tamargo et al.

MOLECULAR GENETICS AND METABOLISM (2012)

Article Neurosciences

Primary Skin Fibroblasts as a Model of Parkinson's Disease

Georg Auburger et al.

MOLECULAR NEUROBIOLOGY (2012)

Article Neurosciences

Alpha-synuclein overexpressing transgenic mice show internal organ pathology and autonomic deficits

Penelope J. Hallett et al.

NEUROBIOLOGY OF DISEASE (2012)

Article Multidisciplinary Sciences

Induced pluripotent stem cell model recapitulates pathologic hallmarks of Gaucher disease

Leelamma M. Panicker et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)

Article Genetics & Heredity

A Mutation in SCARB2 is a Modifier in Gaucher Disease

Arash Velayati et al.

HUMAN MUTATION (2011)

Article Medicine, General & Internal

Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease

E. Sidransky et al.

NEW ENGLAND JOURNAL OF MEDICINE (2009)